// App-Quantinova.ai

1088.0 : Clinical predictors of long-term response to capecitabine in metastatic breast cancer (MBC).

Researchers

Presenter

  • Deirdre Kelly

Principal Investigators

  • Sasha M. Lupichuk

  • Philippe L. Bedard

  • Karen King

  • David W. Cescon

  • Zachary William Neil Veitch

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • St. Michael's Hosp, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Capecitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved